PM
Interesting possibilities!
Also, we have known for some time that the authorized shares limit had to be raised for the reasons already stated.
Sometimes the most obvious indicator of inevitable value creation or at least that management will make every effort to increase shareholder value is management’s alignment with shareholders via their insider ownership!!!
Looking at LP holding 2.8% of the common and gobs of warrants/options representing millions more shares. Similar holdings by the other senior management in shares and options, and even more to be awarded upon certain milestones and events, means complete alignment with respect to increasing the share price or value.
It’s that simple and obvious that their financial success means our financial success!
Now I’ve believed for a long time that LP wants to deliver benefits to the patients more than financial benefits. The results of the phase 3 and the continuation of increasing benefits to patients indicated by the combo treatment work means Mission 1 is being delivered on.
The financial rewards and strengthening the company to prosper and deliver on the potential of the platform is Mission 2 but necessary to sustain Mission 1.
Does anyone truly believe LP and company has come this far, and with so much personal commitment and aligned huge ownership interest, and not get it done?
LP is well noted for saying Go Big or Go Home, and my opinion and money is on nwbo succeeding big!
Regarding the ASM, if one assumes getting one done in 2022 is important and probably best not to be exposed to consequences, and if approximately 30 days advance notice is required, and the peer reviewed JA was felt necessary to have been published in a top journal, then you are left scheduling the ASM for one of the last non-holiday days of the year, hence December 30th.
